Centrosome-kinase fusions promote oncogenic signaling and disrupt centrosome function in myeloproliferative neoplasms.

Chromosomal translocations observed in myeloproliferative neoplasms (MPNs) frequently fuse genes that encode centrosome proteins and tyrosine kinases. This causes constitutive activation of the kinase resulting in aberrant, proliferative signaling. The function of centrosome proteins in these fusion...

Full description

Bibliographic Details
Main Authors: Joanna Y Lee, Wan-Jen Hong, Ravindra Majeti, Tim Stearns
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3962438?pdf=render
_version_ 1818488214216769536
author Joanna Y Lee
Wan-Jen Hong
Ravindra Majeti
Tim Stearns
author_facet Joanna Y Lee
Wan-Jen Hong
Ravindra Majeti
Tim Stearns
author_sort Joanna Y Lee
collection DOAJ
description Chromosomal translocations observed in myeloproliferative neoplasms (MPNs) frequently fuse genes that encode centrosome proteins and tyrosine kinases. This causes constitutive activation of the kinase resulting in aberrant, proliferative signaling. The function of centrosome proteins in these fusions is not well understood. Among others, kinase centrosome localization and constitutive kinase dimerization are possible consequences of centrosome protein-kinase fusions. To test the relative contributions of localization and dimerization on kinase signaling, we targeted inducibly dimerizable FGFR1 to the centrosome and other subcellular locations and generated a mutant of the FOP-FGFR1 MPN fusion defective in centrosome localization. Expression in mammalian cells followed by western blot analysis revealed a significant decrease in kinase signaling upon loss of FOP-FGFR1 centrosome localization. Kinase dimerization alone resulted in phosphorylation of the FGFR1 signaling target PLCγ, however levels comparable to FOP-FGFR1 required subcellular targeting in addition to kinase dimerization. Expression of MPN fusion proteins also resulted in centrosome disruption in epithelial cells and transformed patient cells. Primary human MPN cells showed masses of modified tubulin that colocalized with centrin, Smoothened (Smo), IFT88, and Arl13b. This is distinct from acute myeloid leukemia (AML) cells, which are not associated with centrosome-kinase fusions and had normal centrosomes. Our results suggest that effective proliferative MPN signaling requires both subcellular localization and dimerization of MPN kinases, both of which may be provided by centrosome protein fusion partners. Furthermore, centrosome disruption may contribute to the MPN transformation phenotype.
first_indexed 2024-12-10T16:48:06Z
format Article
id doaj.art-32bbffb16de54672b1a122bbc09662bd
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-10T16:48:06Z
publishDate 2014-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-32bbffb16de54672b1a122bbc09662bd2022-12-22T01:40:59ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0193e9264110.1371/journal.pone.0092641Centrosome-kinase fusions promote oncogenic signaling and disrupt centrosome function in myeloproliferative neoplasms.Joanna Y LeeWan-Jen HongRavindra MajetiTim StearnsChromosomal translocations observed in myeloproliferative neoplasms (MPNs) frequently fuse genes that encode centrosome proteins and tyrosine kinases. This causes constitutive activation of the kinase resulting in aberrant, proliferative signaling. The function of centrosome proteins in these fusions is not well understood. Among others, kinase centrosome localization and constitutive kinase dimerization are possible consequences of centrosome protein-kinase fusions. To test the relative contributions of localization and dimerization on kinase signaling, we targeted inducibly dimerizable FGFR1 to the centrosome and other subcellular locations and generated a mutant of the FOP-FGFR1 MPN fusion defective in centrosome localization. Expression in mammalian cells followed by western blot analysis revealed a significant decrease in kinase signaling upon loss of FOP-FGFR1 centrosome localization. Kinase dimerization alone resulted in phosphorylation of the FGFR1 signaling target PLCγ, however levels comparable to FOP-FGFR1 required subcellular targeting in addition to kinase dimerization. Expression of MPN fusion proteins also resulted in centrosome disruption in epithelial cells and transformed patient cells. Primary human MPN cells showed masses of modified tubulin that colocalized with centrin, Smoothened (Smo), IFT88, and Arl13b. This is distinct from acute myeloid leukemia (AML) cells, which are not associated with centrosome-kinase fusions and had normal centrosomes. Our results suggest that effective proliferative MPN signaling requires both subcellular localization and dimerization of MPN kinases, both of which may be provided by centrosome protein fusion partners. Furthermore, centrosome disruption may contribute to the MPN transformation phenotype.http://europepmc.org/articles/PMC3962438?pdf=render
spellingShingle Joanna Y Lee
Wan-Jen Hong
Ravindra Majeti
Tim Stearns
Centrosome-kinase fusions promote oncogenic signaling and disrupt centrosome function in myeloproliferative neoplasms.
PLoS ONE
title Centrosome-kinase fusions promote oncogenic signaling and disrupt centrosome function in myeloproliferative neoplasms.
title_full Centrosome-kinase fusions promote oncogenic signaling and disrupt centrosome function in myeloproliferative neoplasms.
title_fullStr Centrosome-kinase fusions promote oncogenic signaling and disrupt centrosome function in myeloproliferative neoplasms.
title_full_unstemmed Centrosome-kinase fusions promote oncogenic signaling and disrupt centrosome function in myeloproliferative neoplasms.
title_short Centrosome-kinase fusions promote oncogenic signaling and disrupt centrosome function in myeloproliferative neoplasms.
title_sort centrosome kinase fusions promote oncogenic signaling and disrupt centrosome function in myeloproliferative neoplasms
url http://europepmc.org/articles/PMC3962438?pdf=render
work_keys_str_mv AT joannaylee centrosomekinasefusionspromoteoncogenicsignalinganddisruptcentrosomefunctioninmyeloproliferativeneoplasms
AT wanjenhong centrosomekinasefusionspromoteoncogenicsignalinganddisruptcentrosomefunctioninmyeloproliferativeneoplasms
AT ravindramajeti centrosomekinasefusionspromoteoncogenicsignalinganddisruptcentrosomefunctioninmyeloproliferativeneoplasms
AT timstearns centrosomekinasefusionspromoteoncogenicsignalinganddisruptcentrosomefunctioninmyeloproliferativeneoplasms